@incollection{, 6CF7DB092F25A2E5F1FFA3ED0710F3F7 , author={{Manash PratimSarma} and {Manash PratimSarma} and {Assam down town University}}, journal={{Global Journal of Medical Research}}, journal={{GJMR}}2249-46180975-588810.34257/GJMR, address={Cambridge, United States}, publisher={Global Journals Organisation}1643136 } @book{b0, , title={{Metabolic Interaction of Helicobacter pylori Infection and Gut Microbiota. Microorganisms: 4}} , author={{ Yao-JongYang } and { Bor-ShyangSheu }} , year={2016} 15 } @incollection{b1, , title={{Management of Helicobacter Pylori Infection}} , author={{ NicholasMartinez } and { MDKarthik Garapati } and { MD } and { CharlesRandall } and { MD }} , journal={{Journal of Tropical Diseases}} 2 1 , year={2014} } @incollection{b2, , title={{Iron deficiency anemia in Helicobacter pylori infection: meta-analysis of randomized controlled trials}} , author={{ WYuan } and { LiYumin } and { YangKehu } and { MaBin } and { GuanQuanlin }} , journal={{Scand J Gastroenterol}} 45 , year={2010} } @incollection{b3, , title={{Treatment of Helicobacter pylori}} , author={{ BJEgan } and { MKaticic } and { HJO'connor } and { CAO'morain }} , journal={{Helicobacter}} 12 , year={2007} , note={Suppl.1} } @book{b4, , title={{}} , author={{ MJJanssen } and { LHendrikse } and { SYDe Boer } and { RBosboom } and { WADe Boer } and { RJLaheij } and { JBJansen }} , year={2006} } @incollection{b5, , title={{Helicobacter pylori antibiotic resistance in a Dutch region: trends over time}} , journal={{Neth J Med}} 64 } @book{b6, , title={{Helicobacter pylori Eradication: Decision Making in Clinical Practice, MP Sharma, Medicine Update}} 64 } @book{b7, , title={{World Gastroenterology Organisation Global Guidelines Report on Helicobacter pylori in developing countries}} , year={August 2010} } @incollection{b8, , title={{Helicobacter pylori eradication therapy: A review of current trends}} , author={{ ABOlokoba } and { OAObateru1 } and { MOBojuwoye }} , journal={{Nigerian Medical Journal}} 54 , year={2013} } @incollection{b9, , title={{High eradication rates of Helicobacter pylori with a new sequential treatment}} , author={{ AZullo } and { DVaira } and { NVakil } and { CHassan } and { LGatta } and { CRicci }} , journal={{Aliment Pharmacol Ther}} 17 , year={2003} } @incollection{b10, , title={{A historical perspective on Helicobacter gastroduodenitis and its complications}} , author={{ BJEgan } and { CAO'morain }} , journal={{Best Pract Res Clin Gastroenterol}} 21 , year={2007} , note={Review} } @incollection{b11, , title={{Current concepts in the management of Helicobacter pylori infection -The Maastricht III Consensus Report}} , author={{ PMalfertheiner } and { FMegraud } and { CO'morain }} , journal={{Gut}} 56 , year={2007} } @incollection{b12, , title={{The trends of one-week first-line and second-line eradication therapy for Helicobacter pylori infection in Korea}} , author={{ JWChung } and { GHLee } and { JHHan }} , journal={{Hepatogastroenterology}} 58 , year={2011} } @incollection{b13, , title={{Trends in the eradication rates of Helicobacter pylori infection for eleven years}} , author={{ JHYoon } and { GHBaik } and { KMSohn }} , journal={{World J Gastroenterol}} 18 , year={2012} } @incollection{b14, , title={{Trends in the eradication rates of Helicobacter pylori infection in Daegu and Gyeongsangbuk-do, Korea: multicenter study over 13 years}} , author={{ YSJung } and { SHLee } and { CSPark }} , journal={{Korean J Gastroenterol}} 63 , year={2014} } @incollection{b15, , title={{Does standard triple therapy still have a role in first-line Helicobacter pylori eradication in Korea?}} , author={{ HKJeon } and { GHKim }} , journal={{J Korean Med Sci}} 29 , year={2014} } @incollection{b16, , title={{Metaanalysis of first-line triple therapy for helicobacter pylori eradication in Korea: is it time to change?}} , author={{ EJGong } and { SCYun } and { HYJung }} , journal={{J Korean Med Sci}} 29 , year={2014} } @incollection{b17, , title={{Rational Helicobacter pylori therapy: evidence-based medicine rather than medicine-based evidence}} , author={{ DYGraham } and { YCLee } and { MSWu }} , journal={{Clin Gastroenterol Hepatol}} 12 , year={2014. 2014} , note={Evidencebased recommendations for successful} } @incollection{b18, , title={{}} , journal={{Helicobacter pylori treatment. Expert Rev Gastroenterol Hepatol}} 8 } @incollection{b19, , title={{Pharmacologic aspects of eradication therapy for Helicobacter pylori Infection}} , author={{ TFuruta } and { DYGraham }} , journal={{Gastroenterol Clin North Am}} 39 , year={2010} } @incollection{b20, , title={{}} , journal={{Global Journal of Medical Research}} } @incollection{b21, , title={{Triple vs quadruple therapy for treating Helicobacter pylori infection: an updated meta-analysis}} , author={{ EGené } and { XCalvet } and { RAzagra } and { JPGisbert }} , journal={{Aliment Pharmacol Ther}} 18 , year={2003} } @incollection{b22, , title={{Which Therapy for Helicobacter pylori Infection}} , author={{ DYGraham } and { AShiotani }} , journal={{Gastroenterology}} 143 , year={2012} } @incollection{b23, , title={{Meta-analysis: the effect of antibiotic resistance status on the efficacy of triple and quadruple first-line therapies for Helicobacter pylori}} , author={{ LFischbach } and { ELEvans }} , journal={{Aliment Pharmacol Ther}} 26 , year={2007} } @incollection{b24, , title={{Treatment of Helicobacter pylori infection 2012}} , author={{ BTepes } and { AO'connor } and { JPGisbert } and { O'morain } and { C }} , journal={{Helicobacter}} 17 , year={2012} , note={Suppl} } @incollection{b25, , title={{Pattern of primary resistance of Helicobacter pylori to metronidazole or clarithromycin in the United States}} , author={{ MSOsato } and { RReddy } and { SGReddy } and { RLPenl } and { HMMalaty }} , journal={{Arch Intern Med}} 161 , year={2001} } @incollection{b26, , title={{Bismuth based quadruple therapy using a single capsule of bismuth biskal citrate, metronidazole, and tetracycline given with omeprazole versus omeprazole, amoxicillin and clarithromycin for eradication of Helicobacter pylori in duodenalulcer patients: A prospective, randomized, multicenter North American trial}} , author={{ LLaine } and { RHunt } and { HEl-Zimaity } and { BNguyen } and { MOsato }} , journal={{AmJ Gastroenterol}} 98 , year={2003} } @incollection{b27, , title={{Is it time for quadruple therapy to be first line?}} , author={{ LLaine }} , journal={{Can J Gastroenterol}} 17 , year={2003} , note={Suppl B} } @incollection{b28, , title={{Third-line rescue therapy for Helicobacter pylori infection}} , author={{ RCianci } and { MMontalto } and { FPandolfi } and { GBGasbarrini } and { GCammarota }} , journal={{World J Gastroenterol}} 12 , year={2006} } @incollection{b29, , title={{}} , author={{ JSHua } and { PYZheng } and { TKFong } and { MMKhin } and { HBow }} , journal={{Helicobacterpylori J Gastroenterol}} 4 , year={1998} } @book{b30, , title={{High efficacy of 1-week doxycycline-and amoxicillin-based quadruple regimen in a culture-guided, third-line treatment approach for Helicobacter pylori infection}} , author={{ GCammarota } and { AMartino } and { GPirozzi } and { RCianci } and { GBranca } and { ECNista }} , year={2004} } @incollection{b31, , title={{}} , journal={{Aliment Pharmacol Ther}} 19 } @incollection{b32, , title={{Efficacy of levofloxacin and rifaximin based quadruple therapy in Helicobacter pylori associated gastroduodenal disease: A double-blind, randomized controlled trial}} , author={{ KHChoi } and { WCChung } and { KMLee } and { CNPaik } and { EJKim } and { BKKang }} , journal={{J Korean-Med Sci}} 26 , year={2011} } @incollection{b33, , title={{Helicobacter pylori -Current Therapy and Future Therapeutic Strategies}} , journal={{Rajinikanth Siddalingam and Kumarappan Chidambaram. INTECH}} 10 }